novo nordisk wegovy - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

The Motley Fool on MSN · 44m

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

CBS News on MSN · 18h

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Insider on MSN · 7h

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

Novo Nordisk launches weight-loss drug Wegovy

Reuters on MSN · 54m

Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro

By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss drug Wegovy in the world's most populous nation, in a move that will challenge rival Eli Lilly's Mounjaro,

Times Now · 16m

Novo Nordisk Launches Weight-loss Drug Wegovy in India; How Does It Work?

Novo Nordisk has launched Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce heart risks amid the country's growing obesity crisis. Wegovy, which has semaglutide,

Pharmabiz · 20m

Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication

Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: Our Bureau, Bengaluru Tuesday, June 24, 2025, 15:45 Hr

15h

Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing" Novo Nordisk said it will stop selling Wegovy on ...

Hims & Hers stock crashes over 20% on Wegovy shocker

Hims & Hers Health stock plunged after Novo Nordisk (NYSE: NVO) cut ties over concerns about its handling of Wegovy ...

24/7 Wall St.3d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

3don MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

GlobalData on MSN5d

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

The Pharma Letter3d

High-dose Wegovy cuts weight 21%, new data shows

At a time when Novo Nordisk has appeared to be slipping behind rival Eli Lilly and its blockbuster Zepbound (tirzepatide) in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results